Cargando…
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome—clinical presentation of a newly described somatic, autoinflammatory syndrome
Autores principales: | Alhomida, Faris, Beck, David B., George, Tracy I., Shaffer, Andrew, Lebiedz-Odrobina, Dorota, Kovacsovics, Tibor, Madigan, Lauren M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313797/ https://www.ncbi.nlm.nih.gov/pubmed/34337120 http://dx.doi.org/10.1016/j.jdcr.2021.06.010 |
Ejemplares similares
-
Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
por: Stubbins, Ryan J., et al.
Publicado: (2022) -
Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review
por: Kouranloo, Koushan, et al.
Publicado: (2023) -
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
por: Goyal, Amrita, et al.
Publicado: (2022) -
A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment
por: Tozaki, Nagie, et al.
Publicado: (2022) -
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)